This trial is testing a new treatment for fecal incontinence. Patients will either receive injections of a bulking agent or biofeedback, and will be monitored for a 75% reduction in fecal incontinence episodes. If the treatment is successful, participants will be followed for an additional 21 months.
3 Primary · 7 Secondary · Reporting Duration: up to 24 months
285 Total Participants · 2 Treatment Groups
Primary Treatment: Biofeedback (BIO) · No Placebo Group · N/A
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: